Thomas Lategan
Consigliere Generale presso BRIGHT MINDS BIOSCIENCES INC.
Posizioni attive di Thomas Lategan
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
| BRIGHT MINDS BIOSCIENCES INC. | Consigliere Generale | 14/06/2021 | - |
Storia della carriera di Thomas Lategan
Precedenti posizioni note di Thomas Lategan
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
NeurAxon, Inc.
 NeurAxon, Inc. Miscellaneous Commercial ServicesCommercial Services NeurAxon, Inc. is engaged in the research and development of growing and unmet needs for chronic pain management. It is focused on developing pain therapeutics targeting neuronal Nitric Oxide Synthase (nNOS) inhibitors. The companyw as founded in 2004 and is headquartered in Mississauga, ON. | Consigliere Generale | 01/09/2008 | 01/11/2015 |
| PANACOS PHARMACEUTICALS, INC. | Consigliere Generale | 01/02/2007 | 01/09/2008 |
Actelion Pharmaceuticals US, Inc.
 Actelion Pharmaceuticals US, Inc. Pharmaceuticals: MajorHealth Technology Part of Johnson & Johnson, Actelion Pharmaceuticals US, Inc. is a company that manufactures, distributes and markets drugs. The company is based in Titusville, NJ. The CEO of the company is Samuele Butera. | Consigliere Generale | 01/02/2000 | 01/02/2007 |
| THE MEDICINES COMPANY | Consigliere Generale | 01/03/1997 | 01/02/2000 |
| Roche Corp. | Corporate Officer/Principal | - | - |
Formazione di Thomas Lategan
| University of Oxford | Doctorate Degree |
| University of Aberdeen | Undergraduate Degree |
Statistiche
Distribuzione geografica
| Stati Uniti | 6 |
| Regno Unito | 3 |
| Canada | 2 |
Posizioni
| General Counsel | 5 |
| Doctorate Degree | 1 |
| Undergraduate Degree | 1 |
Settori
| Health Technology | 5 |
| Consumer Services | 3 |
| Commercial Services | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
| Società quotate in Borsa | 2 |
|---|---|
| PANACOS PHARMACEUTICALS, INC. | Health Technology |
| BRIGHT MINDS BIOSCIENCES INC. | Health Technology |
| Aziende private | 4 |
|---|---|
Actelion Pharmaceuticals US, Inc.
Actelion Pharmaceuticals US, Inc. Pharmaceuticals: MajorHealth Technology Part of Johnson & Johnson, Actelion Pharmaceuticals US, Inc. is a company that manufactures, distributes and markets drugs. The company is based in Titusville, NJ. The CEO of the company is Samuele Butera. | Health Technology |
The Medicines Co.
 The Medicines Co. Pharmaceuticals: MajorHealth Technology The Medicines Co. is a biopharmaceutical company, which focuses on saving lives, alleviating suffering and contributing to the economics of healthcare by focusing on acute and intensive care hospitals worldwide. The firm markets its brands Angiomax, Cleviprex, injectable emulsion, Ionsys, Kengreal, Minocin for injection, and Orbactiv. The company was founded by Clive A. Meanwell, Helmut Giersiefen, John W. Villiger and T. Scott Johnson on July 31, 1996 and is headquartered in Parsippany, NJ. | Health Technology |
NeurAxon, Inc.
NeurAxon, Inc. Miscellaneous Commercial ServicesCommercial Services NeurAxon, Inc. is engaged in the research and development of growing and unmet needs for chronic pain management. It is focused on developing pain therapeutics targeting neuronal Nitric Oxide Synthase (nNOS) inhibitors. The companyw as founded in 2004 and is headquartered in Mississauga, ON. | Commercial Services |
| Roche Corp. |
- Borsa valori
- Insiders
- Thomas Lategan
- Esperienza
